Both in Pharmaceuticals
NextCure vs China Pharma Holdings
Over the past year NXTC returned −38.7% and CPHI returned −64.8%; their daily moves had a correlation of 0.05.
NXTC −38.7% CPHI −64.8%Growth of $1, one year, split-adjusted
| Metric | NXTC | CPHI |
|---|---|---|
| Price | $6.34 | $0.6200 |
| Market cap | $29.0M | $26.7M |
| Today | +10.94% | −1.59% |
| 1 month | +30.9% | −4.6% |
| 6 months | −29.1% | +12.7% |
| Year to date | −55.3% | −48.8% |
| 1 year | −31.6% | — |
| Revenue growth (YoY) | — | −7.5% |
| Gross margin | — | 8.8% |
| Net margin | — | −153.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 6.8× |
| Net cash | $20.1M | -$3.3M |
| Dividend yield | — | — |
| Volatility (60d) | 115.9% | 91.3% |
| Short % of float | 8.4% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).